Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models

…, C Zhong, A Adam, D Scharton, GH Rafael… - Science translational …, 2022 - science.org
Emergence of SARS-CoV-2 variants of concern (VOCs), including the highly transmissible
Omicron and Delta strains, has posed constant challenges to the current COVID-19 vaccines …

Decontamination of SARS-CoV-2 and other RNA viruses from N95 level meltblown polypropylene fabric using heat under different humidities

RK Campos, J Jin, GH Rafael, M Zhao, L Liao… - ACS …, 2020 - ACS Publications
In March of 2020, the World Health Organization declared a pandemic of coronavirus
disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-…

[HTML][HTML] Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA. 5 in male Syrian hamsters

…, JL Walker, D Scharton, GH Rafael… - Nature …, 2023 - nature.com
The SARS-CoV-2 Omicron subvariant BA.5 rapidly spread worldwide and replaced BA.1/BA.2
in many countries, becoming globally dominant. BA.5 has unique amino acid substitutions …

[HTML][HTML] Role of mutational reversions and fitness restoration in Zika virus spread to the Americas

…, BTD Nunes, R Yun, SL Haller, GH Rafael… - Nature …, 2021 - nature.com
Zika virus (ZIKV) emerged from obscurity in 2013 to spread from Asia to the South Pacific
and the Americas, where millions of people were infected, accompanied by severe disease …

[HTML][HTML] Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies

…, A Adam, B Wang, RL Hajnik, Y Liang, GH Rafael… - npj Vaccines, 2021 - nature.com
A candidate multigenic SARS-CoV-2 vaccine based on an MVA vector expressing both viral
N and S proteins (MVA-S + N) was immunogenic, and induced T-cell responses and …

IMMUNO-COV v2. 0: Development and validation of a high-throughput clinical assay for measuring SARS-CoV-2-neutralizing antibody titers

…, A Bexon, S Naik, B Brunton, SC Weaver, G Rafael… - MSphere, 2021 - Am Soc Microbiol
Neutralizing antibodies are key determinants of protection from future infection, yet well-validated
high-throughput assays for measuring titers of SARS-CoV-2-neutralizing antibodies …

Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2

…, A Roesler, JR Mills, E Theel, SC Weaver, G Rafael… - Biorxiv, 2020 - biorxiv.org
We here describe the development and validation of IMMUNO-COV™, a high-throughput
clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset …

PCP consensus protein/peptide alphavirus antigens stimulate broad spectrum neutralizing antibodies

CH Schein, G Rafael, WS Baker, ES Anaya… - Peptides, 2022 - Elsevier
Vaccines based on proteins and peptides may be safer and if calculated based on many
sequences, more broad-spectrum than those designed based on single strains. …

Combinatorial mRNA vaccination enhances protection against SARS-CoV-2 delta variant

…, J Tang, C Zhong, A Adam, D Scharton, GH Rafael… - bioRxiv, 2021 - biorxiv.org
Emergence of SARS-CoV-2 variants of concern (VOC), including the highly transmissible delta
strain, has posed challenges to current COVID-19 vaccines that principally target the viral …

[HTML][HTML] Designing multivalent immunogens for alphavirus vaccine optimization

CM Read, K Plante, G Rafael, SL Rossi, W Braun… - Virology, 2021 - Elsevier
There is a pressing need for vaccines against mosquito-borne alphaviruses such as Venezualen
and eastern equine encephalitis viruses (VEEV, EEEV). We demonstrate an approach …